Furthermore, [68Ga]Ga-NOTA-SNA006a, a nanobody-based tracer targeting CD8, exhibited rapid and persistent uptake in tumour lesions, as well as in CD8-rich tissues in humanised mouse xenografts [118]. This evidence concerns the gene CD8A and neoplasm.